Liver Disease
Conference Coverage
Steroids and G-CSF improve 90-day survival in severe alcoholic hepatitis
In addition to its superior results on the primary endpoint of 90-day survival, combination therapy was associated with significantly better...
Conference Coverage
Liver disease-related deaths rise during pandemic
“The increasing trend in mortality rates for ALD and NAFLD has been quite alarming, with disparities in age, race, and ethnicity.”
Conference Coverage
Living donor liver transplants on rise for most urgent need
Patient survival appears to be comparable to deceased donor liver transplantation.
From the Journals
Chronic hepatitis B infections associated with a range of liver malignancies
Treatment with nucleos(t)ide analogues lowers risk of extrahepatic cancer in patients with hepatitis B infections.
From the Journals
Pediatric celiac disease incidence varies across U.S., Europe
“From a policy standpoint, this informs future screening practices and supports efforts toward mass screening, at least in some areas.”
Conference Coverage
World falls short on HBV, HCV elimination targets
“As countries progress toward eliminating hepatitis B and C, we really need to do more to expand political will and financing of national...
Conference Coverage
NAFLD patients with diabetes have higher fibrosis progression rate
Patients with type 2 diabetes had about a 2-year faster progression to fibrosis.
Conference Coverage
Resmetirom reduces liver, CV risk factors in NASH with cirrhosis
“I do think it could be one of the drugs that really improves outcomes for patients with NASH.”
Conference Coverage
Noninvasive tests may provide prognostic value in NAFLD
Fibrosis biomarkers were significantly predictive of event-free survival probability.
Conference Coverage
Low-carb diet aids weight loss in liver transplant recipients with obesity
The diet didn’t negatively affect serum lipids or renal function.